BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8292163)

  • 1. Screening for colorectal cancer.
    Brown ML
    N Engl J Med; 1993 Oct; 329(18):1352-3. PubMed ID: 8292163
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
    Tsoi KK; Ng SS; Leung MC; Sung JJ
    Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of the faecal occult blood test in screening for colorectal cancer.
    Delcò F; Sonnenberg A
    Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the most cost-effective screening regimen for colon cancer?
    Griffith S; Kane KY
    J Fam Pract; 2001 Jan; 50(1):13. PubMed ID: 11195472
    [No Abstract]   [Full Text] [Related]  

  • 6. Cost-effectiveness analysis of colorectal cancer screening strategies in Singapore: a dynamic decision analytic approach.
    Wong SS; Leong AP; Leong TY
    Stud Health Technol Inform; 2004; 107(Pt 1):104-10. PubMed ID: 15360784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening of colorectal cancer: indications and recommendations for a practical procedure].
    Porschen R
    Z Arztl Fortbild (Jena); 1993 Sep; 87(9):705-10. PubMed ID: 8237065
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness of capsule endoscopy in screening for colorectal cancer.
    Hassan C; Zullo A; Winn S; Morini S
    Endoscopy; 2008 May; 40(5):414-21. PubMed ID: 18302080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Individual screening for colorectal cancer: which strategy for which patient?].
    Demols A; Van Laethem JL; Gay F; Franchimont D; Adler M; Van Gossum A
    Rev Med Brux; 2001 Sep; 22(4):A203-9. PubMed ID: 11680174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
    Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of screening for colorectal cancer.
    Budenholzer B; Welch HG
    Ann Intern Med; 2001 Aug; 135(3):219. PubMed ID: 11487493
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost evaluation in a colorectal cancer screening programme by faecal occult blood test in the District of Florence.
    Grazzini G; Ciatto S; Cislaghi C; Castiglione G; Falcone M; Mantellini P; Zappa M;
    J Med Screen; 2008; 15(4):175-81. PubMed ID: 19106257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Choice of screening modality in a colorectal cancer education and screening program for the uninsured.
    Sarfaty M; Feng S
    J Cancer Educ; 2006; 21(1):43-9. PubMed ID: 16918290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential impact of population-based colorectal cancer screening in Canada.
    Flanagan WM; Le Petit C; Berthelot JM; White KJ; Coombs BA; Jones-McLean E
    Chronic Dis Can; 2003; 24(4):81-8. PubMed ID: 14733756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
    Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening colonoscopy among persons 40 to 49 years of age.
    Romagnuolo J
    N Engl J Med; 2002 Oct; 347(15):1205-6; author reply 1205-6. PubMed ID: 12374885
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for colorectal cancer: the light at the end of the tunnel.
    Caprilli R; Taddei G
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):109-13. PubMed ID: 9646188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.